Mizuho raised the firm’s price target on Delek US (DK) to $27 from $23 and keeps an Outperform rating on the shares. The firm expects the company to report a slight miss versus consensus earnings estimates for Q2. However, Delek US should see improvement in its refining unit due to higher crack spreads, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DK:
- Cautious Outlook for Delek US Holdings Amidst Projected Earnings Shortfall and Limited Growth
- Delek US price target raised to $23 from $22 at Raymond James
- Delek US price target raised to $15 from $11 at Wells Fargo
- Delek US price target raised to $13 from $12 at BofA
- Delek US upgraded to Outperform from Neutral at Mizuho